Research ArticleCANCER IMMUNOLOGY

Targeting latency-associated peptide promotes antitumor immunity

See allHide authors and affiliations

Science Immunology  19 May 2017:
Vol. 2, Issue 11, eaaj1738
DOI: 10.1126/sciimmunol.aaj1738

Article Information

vol. 2 no. 11

PubMed: 
Published By: 
History: 
  • Received September 7, 2016
  • Revision received February 14, 2017
  • Accepted April 20, 2017

Author Information

  1. Galina Gabriely1,
  2. Andre P. da Cunha1,2,
  3. Rafael M. Rezende1,
  4. Brendan Kenyon1,
  5. Asaf Madi1,
  6. Tyler Vandeventer1,
  7. Nathaniel Skillin1,
  8. Stephen Rubino1,
  9. Lucien Garo1,
  10. Maria A. Mazzola1,
  11. Panagiota Kolypetri1,
  12. Amanda J. Lanser1,
  13. Thais Moreira3,
  14. Ana Maria C. Faria3,
  15. Hans Lassmann4,
  16. Vijay Kuchroo1,
  17. Gopal Murugaiyan1 and
  18. Howard L. Weiner1,*
  1. 1Ann Romney Center for Neurologic Diseases, Evergrande Center for Immunologic Diseases, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115, USA.
  2. 2Novartis Institutes for BioMedical Research, Cambridge, MA 02139, USA.
  3. 3Department of Biochemistry and Immunology, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte 31.270-901, Brazil.
  4. 4Center for Brain Research, Medical University of Vienna, Spitalgasse 4, A-1090 Wien, Austria.
  1. *Corresponding author. Email: hweiner{at}rics.bwh.harvard.edu

Altmetric

Article usage

Article usage: May 2017 to November 2017

AbstractFullPdf
May 20179792126300
Jun 2017234851130
Jul 20177771647
Aug 20175672953
Sep 20173891523
Oct 20173891730
Nov 2017217911